These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31560079)

  • 1. [Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants].
    Löser C; Nast A; Zeymer U
    Hautarzt; 2019 Nov; 70(11):850-853. PubMed ID: 31560079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery.
    Siscos SM; Neill BC; Singh AH; Hocker TLH
    J Am Acad Dermatol; 2021 Feb; 84(2):425-431. PubMed ID: 33045293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment.
    McGrail R; Revsholm J; Nissen PH; Grove EL; Hvas AM
    Thromb Res; 2016 Dec; 148():107-110. PubMed ID: 27835819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using new oral anticoagulants in patients undergoing major orthopedic surgery.
    Bass AR
    Curr Rheumatol Rep; 2015 Apr; 17(4):25. PubMed ID: 25854486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the cost-utility of direct oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in Spain].
    Monreal-Bosch M; Soulard S; Crespo C; Brand S; Kansal A
    Rev Neurol; 2017 Mar; 64(6):247-256. PubMed ID: 28272725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation.
    Ferreira J; Mirco A
    Rev Port Cardiol; 2015 Mar; 34(3):179-91. PubMed ID: 25727748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
    Hansen PS; Sanchez R; Walfridsson H
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).
    Barequet IS; Zehavi-Dorin T; Bourla N; Tamarin I; Moisseiev J; Salomon O
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2671-2676. PubMed ID: 31641883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications.
    Crivera C; Nelson WW; Bookhart B; Martin S; Germain G; Laliberté F; Schein J; Lefebvre P
    Curr Med Res Opin; 2015; 31(10):1889-95. PubMed ID: 26211815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.
    Sivolella S; De Biagi M; Brunello G; Berengo M; Pengo V
    Odontology; 2015 Sep; 103(3):258-63. PubMed ID: 25656043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Novel Oral Anticoagulants vs Low Molecular Weight Heparin for Thromboprophylaxis in Large-Volume Liposuction and Body Contouring Procedures.
    Morales R; Ruff E; Patronella C; Mentz H; Newall G; Hustak KL; Fortes P; Bush A
    Aesthet Surg J; 2016 Apr; 36(4):440-9. PubMed ID: 26961988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants (DOACs).
    Vazquez S; Rondina MT
    Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study.
    Antia C; Hone N; Gloster H
    J Am Acad Dermatol; 2017 Nov; 77(5):967-968. PubMed ID: 29029905
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulants: What is new and what is the standard?
    Lesko LJ
    Clin Pharmacol Ther; 2016 Aug; 100(2):126-8. PubMed ID: 27197625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
    Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of novel oral anticoagulants in Australia.
    Pratt NL; Ramsay EN; Caughey GE; Shakib S; Roughead EE
    Med J Aust; 2016 Feb; 204(3):104-5.e1. PubMed ID: 26866544
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure.
    McHorney CA; Crivera C; Laliberté F; Nelson WW; Germain G; Bookhart B; Martin S; Schein J; Lefebvre P; Deitelzweig S
    Curr Med Res Opin; 2015 Dec; 31(12):2167-73. PubMed ID: 26393483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery.
    Johnston S
    Int J Oral Maxillofac Surg; 2016 May; 45(5):618-30. PubMed ID: 26774397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
    PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.